Brilinta, a new antiplatelet drug
You'll hear lots of buzz about Brilinta, a new antiplatelet drug.
Brilinta (ticagrelor) will compete with Plavix (clopidogrel) and Effient (prasugrel)...for acute coronary syndrome or after a stent.
Plavix will still lead the pack...for a while. It was the first one approved and is used the most. But it's not perfect.